Longitudinal lipoprotein and inflammatory mediators analysis uncover persisting inflammation and hyperlipidemia following SARS-CoV-2 infection in long COVID-19
Our findings demonstrate a persistent hyperlipidemic phenotype in LC alongside signs of chronic inflammation and lipoprotein metabolism that vary in states of acute and chronic inflammation.
Authors
- Zhiqi Yang (ORCID: https://orcid.org/0000-0001-5003-8507)
- Caterina Lonati (ORCID: https://orcid.org/0000-0001-7855-7851)
- Yogesh Singh (ORCID: https://orcid.org/0000-0001-6919-6273)
- Christoph Trautwein (ORCID: https://orcid.org/0000-0003-4672-6395)
- Gyuntae Bae
- Claire Wegner
- Hartmut Schäfer
- Daniele Bucci
Institutions
- Siemens (Germany) (DE)
- Bruker (United States) (US)
- Bernstein Center for Computational Neuroscience Tübingen (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Metabolomics
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1007/s11306-025-02262-y
- Citations
- 6
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 8.34
Funders
- Universitätsklinikum Tübingen